ECSP066768A - Procedimiento para la preparacion de compuestos triazol sustituidos - Google Patents

Procedimiento para la preparacion de compuestos triazol sustituidos

Info

Publication number
ECSP066768A
ECSP066768A EC2006006768A ECSP066768A ECSP066768A EC SP066768 A ECSP066768 A EC SP066768A EC 2006006768 A EC2006006768 A EC 2006006768A EC SP066768 A ECSP066768 A EC SP066768A EC SP066768 A ECSP066768 A EC SP066768A
Authority
EC
Ecuador
Prior art keywords
preparation
procedure
substituted triazol
triazol compounds
compounds
Prior art date
Application number
EC2006006768A
Other languages
English (en)
Inventor
Kirk Leonard Sorgi
David C Palmer
Tong Xiao
Sergio Cesco-Cancian
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34864531&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP066768(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of ECSP066768A publication Critical patent/ECSP066768A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/14—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invención se dirige a un procedimiento novedoso para la preparación de compuestos triazol sustituidos, útiles en el tratamiento o mejoría de un trastorno mediado por cinasa selectiva o mediado por cinasa dual; el procedimiento de la presente invención preferencialmente produce el regioisómero deseado de los compuestos triazol sustituidos.
EC2006006768A 2004-02-11 2006-08-10 Procedimiento para la preparacion de compuestos triazol sustituidos ECSP066768A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54372104P 2004-02-11 2004-02-11
US62368104P 2004-10-29 2004-10-29

Publications (1)

Publication Number Publication Date
ECSP066768A true ECSP066768A (es) 2006-11-16

Family

ID=34864531

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2006006768A ECSP066768A (es) 2004-02-11 2006-08-10 Procedimiento para la preparacion de compuestos triazol sustituidos

Country Status (16)

Country Link
US (1) US20060100259A1 (es)
EP (1) EP1720843A2 (es)
JP (1) JP2007522213A (es)
KR (1) KR20070036025A (es)
AR (1) AR047544A1 (es)
AU (1) AU2005212218A1 (es)
BR (1) BRPI0507634A (es)
CA (1) CA2555825A1 (es)
CR (1) CR8562A (es)
EA (1) EA200601441A1 (es)
EC (1) ECSP066768A (es)
IL (1) IL177315A0 (es)
MX (1) MXPA06009193A (es)
NO (1) NO20063991L (es)
TW (1) TW200538116A (es)
WO (1) WO2005077922A2 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008515925A (ja) * 2004-10-08 2008-05-15 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ １，２，４−トリアゾリルアミノアリール（ヘテロアリール）スルホンアミド誘導体
US7884119B2 (en) 2005-09-07 2011-02-08 Rigel Pharmaceuticals, Inc. Triazole derivatives useful as Axl inhibitors
JP2010514810A (ja) 2006-12-29 2010-05-06 ライジェル ファーマシューティカルズ， インコーポレイテッド Ａｘｌインヒビターとして有用な置換トリアゾール
AU2007342005A1 (en) 2006-12-29 2008-07-10 Rigel Pharmaceuticals, Inc. N3-heteroaryl substituted triazoles and N5-heteroaryl substituted triazoles useful as Axl inhibitors
EP2114954B1 (en) 2006-12-29 2013-02-13 Rigel Pharmaceuticals, Inc. Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as axl inhibitors
ES2404668T3 (es) 2006-12-29 2013-05-28 Rigel Pharmaceuticals, Inc. Triazoles sustituidos con arilo bicíclico puenteado y heteroarilo bicíclico puenteado, útiles como agentes inhibidores del axl
PT2078010E (pt) 2006-12-29 2014-05-07 Rigel Pharmaceuticals Inc Triazoles substituídos com heteroarilos policíclicos úteis como inibidores de axl
CA2704052C (en) 2007-10-26 2015-04-21 Rigel Pharmaceuticals, Inc. Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as axl inhibitors
JP5592884B2 (ja) 2008-07-09 2014-09-17 ライジェル ファーマシューティカルズ， インコーポレイテッド Ａｘｌ阻害剤として有用な多環式ヘテロアリール置換トリアゾール
US8431594B2 (en) 2008-07-09 2013-04-30 Rigel Pharmaceuticals, Inc. Bridged bicyclic heteroaryl substituted triazoles useful as AXL inhibitors
RU2555326C2 (ru) 2009-01-16 2015-07-10 Риджел Фармасьютикалз, Инк. ИНГИБИТОРЫ Axl ДЛЯ ПРИМЕНЕНИЯ В КОМБИНИРОВАННОЙ ТЕРАПИИ ДЛЯ ПРЕДОТВРАЩЕНИЯ, УСТРАНЕНИЯ ИЛИ ЛЕЧЕНИЯ МЕТАСТAЗИРУЮЩЕГО РАКА
US20140010783A1 (en) * 2012-07-06 2014-01-09 Hoffmann-La Roche Inc. Antiviral compounds
CN116003336B (zh) * 2023-01-09 2024-11-05 赣南师范大学 一种1,2,4-三氮唑-3-胺类化合物及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2432870A1 (en) * 2000-12-22 2002-07-25 Ronghui Lin Substituted triazole diamine derivatives as kinase inhibitors
AR042052A1 (es) * 2002-11-15 2005-06-08 Vertex Pharma Diaminotriazoles utiles como inhibidores de proteinquinasas

Also Published As

Publication number Publication date
IL177315A0 (en) 2006-12-10
TW200538116A (en) 2005-12-01
WO2005077922A2 (en) 2005-08-25
JP2007522213A (ja) 2007-08-09
NO20063991L (no) 2006-11-08
KR20070036025A (ko) 2007-04-02
WO2005077922A3 (en) 2006-01-26
EA200601441A1 (ru) 2007-02-27
MXPA06009193A (es) 2007-01-26
AU2005212218A1 (en) 2005-08-25
US20060100259A1 (en) 2006-05-11
EP1720843A2 (en) 2006-11-15
AR047544A1 (es) 2006-01-25
CA2555825A1 (en) 2005-08-25
BRPI0507634A (pt) 2007-07-03
CR8562A (es) 2008-09-09

Similar Documents

Publication Publication Date Title
ECSP088210A (es) Bencimidazoles sustituidos y métodos de preparación
MA32319B1 (fr) Derives de triazine utiles comme inhibiteurs de la kinase pi3 et de mtor
PT2421879E (pt) Novos 7-deazapurina nucleósidos para utilizações terapêuticas
MX346924B (es) Compuestos de diarilhidantoina.
WO2009079008A8 (en) Benzopyrans and analogs as rho kinase inhibitors
MX2010012298A (es) Activadores de glucocinasa.
MX2009003382A (es) Derivados de sulfonamidas sustituidos.
NO20080675L (no) P38-Map kinaseinhibitorer og metoder for deres anvendelse
WO2007059257A3 (en) N4-phenyl-quinaz0line-4 -amine derivatives and related compounds as erbb type i receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases
CR8562A (es) Procedimiento para la preparacion de compuestos de triazol sustituidos
MX2007003108A (es) Compuestos imidazo-3-il-amina sustituidos y biciclicos.
NO20081788L (no) Cyklopropylaminer som modulatorer av histamin-H3-reseptoren
EA200971068A1 (ru) Триазолиламинопиримидиновые соединения
CL2008001074A1 (es) Uso de compuestos de triazol, antagonistas de smo para tratar cancer.
EA200970402A1 (ru) Триазолопиридазиновые модуляторы протеинкиназ
NO20085029L (no) Substituerte pyridylamidforbindelser som modulatorer av histamin H3 reseptoren
EA201170831A1 (ru) Аминопиразольное соединение
CR11098A (es) Compuestos de pirido [2,3-d] pirimidina-7-ona como inhibidores de p13k-alfa para el tratamiento del cancer
PL1891004T3 (pl) Pentafluorosulfanylo-podstawiony związek i jego zastosowanie do wytwarzania środków leczniczych
CR20110368A (es) Compuestos de quinazolina sustituidos
TW200740814A (en) Compounds
MX2007011847A (es) Derivados de pirimidindiona como antagonistas del receptor de procineticina 2.
TW200700064A (en) Novel compounds
MY158253A (en) Cycloalkyloxy- and heterocycloalkyloxypyridine compounds as modulators of the histamine h3 receptor
CL2009002145A1 (es) Metodo de preparacion de derivados de pirrolidona utilizando la sintesis malonica; y los compuestos intermediarios considerados en el metodo.